Asia Pacific Newborn Screening Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Newborn Screening Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Newborn Screening Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Advancements in Methods for Screening Infants for Genetic Disorders hold Immense Potential for the Overall Newborn Screening Market

5.2 Market Opportunities

5.2.1 Integration of Machine Learning and Artificial Intelligence (AI) in Screening

5.3 Future Trends

5.3.1 Rising Burden of Congenital Diseases Leads to an Increase in Demand for Newborn Screening

5.4 Impact of Drivers and Restraints

6. Asia Pacific Newborn Screening Market Regional Analysis

6.1 Asia Pacific Newborn Screening Market Overview

6.2 Asia Pacific Newborn Screening Market Revenue 2020-2030 (US$ Million)

6.3 Asia Pacific Newborn Screening Market Forecast Analysis

7. Asia Pacific Newborn Screening Market Analysis – by Product Type

7.1 Reagents and Assay Kits

7.1.1 Overview
7.1.2 Reagents and Assay Kits: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Newborn Screening Market Analysis – by Technology

8.1 Tandem Mass Spectrometry

8.1.1 Overview
8.1.2 Tandem Mass Spectrometry: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Molecular Assays

8.2.1 Overview
8.2.2 Molecular Assays: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Immunoassays and Enzymatic Assays

8.3.1 Overview
8.3.2 Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Pulse Oximetry Screening Technology

8.4.1 Overview
8.4.2 Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Newborn Screening Market Analysis – by Test Type

9.1 Dry Blood Spot Test

9.1.1 Overview
9.1.2 Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Hearing Screen Test

9.2.1 Overview
9.2.2 Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Critical Congenital Heart Diseases Test

9.3.1 Overview
9.3.2 Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Newborn Screening Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Newborn Screening Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Asia Pacific Newborn Screening Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 China: Asia Pacific Newborn Screening Market Breakdown, by Product Type
10.1.1.1.2 China: Asia Pacific Newborn Screening Market Breakdown, by Technology
10.1.1.1.3 China: Asia Pacific Newborn Screening Market Breakdown, by Test Type

10.1.1.2 India: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 India: Asia Pacific Newborn Screening Market Breakdown, by Product Type
10.1.1.2.2 India: Asia Pacific Newborn Screening Market Breakdown, by Technology
10.1.1.2.3 India: Asia Pacific Newborn Screening Market Breakdown, by Test Type

10.1.1.3 Japan: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Newborn Screening Market Breakdown, by Product Type
10.1.1.3.2 Japan: Asia Pacific Newborn Screening Market Breakdown, by Technology
10.1.1.3.3 Japan: Asia Pacific Newborn Screening Market Breakdown, by Test Type

10.1.1.4 Australia: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Newborn Screening Market Breakdown, by Product Type
10.1.1.4.2 Australia: Asia Pacific Newborn Screening Market Breakdown, by Technology
10.1.1.4.3 Australia: Asia Pacific Newborn Screening Market Breakdown, by Test Type

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Newborn Screening Market Breakdown, by Product Type
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Newborn Screening Market Breakdown, by Technology
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Newborn Screening Market Breakdown, by Test Type

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Newborn Screening Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bio-Rad Laboratories Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 LifeCell International Pvt Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Masimo Corp

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Medtronic Plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Natus Medical Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 PerkinElmer Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Trivitron Healthcare Pvt Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Waters Corp

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights